Skip to main content

Combined Oral Contraceptives Containing Ethinyl Estradiol and Levonorgestrel and Venous Thromboembolism

Basic Details
Date Posted
Status
Complete
Medical Product
combined oral contraceptive (COC)
Health Outcome(s)
venous thromboembolism (VTE)
Description

This report contains estimates of the risk of venous thromboembolism (VTE) among new users of combined oral contraceptives (COCs) containing ethinyl estradiol and levonorgestrel. Data from May 22, 2007 to September 30, 2015 from 16 health plans contributing to the Sentinel Distributed Database (SDD) were included in this report. This request was distributed on June 24, 2016. 

Deliverables (1)
Sentinel Modular Program Report: Combined Oral Contraceptives Containing Ethinyl Estradiol and Levonorgestrel and Venous Thromboembolism
Additional Details
FDA Center
CDER
Time Period
2007-2015
Analysis Type
Descriptive
Population / Cohort
Females 18 to 50 years of age
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Study: Continuous or Extended Cycle Oral Contraceptives & Venous Thromboembolism (VTE)